IV 
115TH CONGRESS 
1ST SESSION 
H. RES. 310 
Expressing support for the designation of May as ‘‘National Bladder Cancer 
Awareness Month’’. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 3, 2017 
Mr. CARTWRIGHT (for himself, Mr. DELANEY, Mr. GALLEGO, Ms. JACKSON 
LEE, Mr. MCGOVERN, Ms. NORTON, Ms. SPEIER, and Mr. YARMUTH) 
submitted the following resolution; which was referred to the Committee 
on Energy and Commerce 
RESOLUTION 
Expressing support for the designation of May as ‘‘National 
Bladder Cancer Awareness Month’’. 
Whereas more than 500,000 families in the United States 
live with bladder cancer; 
Whereas more than 79,000 people are expected to be diag-
nosed with bladder cancer and over 16,000 will die due 
to the disease in 2017 alone; 
Whereas bladder cancer affects people of all ages and back-
grounds and is among the top 10 cancers with the high-
est incidence rates in the United States; 
Whereas bladder cancer is known as one of the most expen-
sive cancers to treat on a per patient basis with a recur-
VerDate Sep 11 2014 
03:31 May 04, 2017
Jkt 069200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR310.IH
HR310
lotter on DSK5VPTVN1PROD with BILLS
•HRES 310 IH 
rence rate of approximately 50 to 80 percent, requiring 
lifelong surveillance; 
Whereas bladder cancer symptoms, such as blood in the 
urine, are easily recognized, however, many are unaware 
of the threat of bladder cancer, often prolonging time to 
diagnosis; 
Whereas if diagnosed early, bladder cancer is treatable; 
Whereas military veterans are twice as likely as non-veterans 
to be diagnosed with bladder cancer; 
Whereas women are often diagnosed at a later stage in the 
development of bladder cancer, and when diagnosed at 
the same stage as men, women have a worse prognosis; 
Whereas if diagnosis and treatment are delayed, the life ex-
pectancy of an individual with bladder cancer decreases; 
Whereas the quality of life of a person with bladder cancer 
will depend on future treatment and diagnosis develop-
ments, which will rely on research advancements; 
Whereas there have been no new treatments developed for 
bladder cancer in more than 20 years; 
Whereas research advancements for bladder cancer are lim-
ited by lack of awareness about the disease within the 
medical community and general public; 
Whereas increased awareness will promote early diagnosis 
and increase chances of survival; 
Whereas increased awareness will bolster public support of 
the disease and thus increase funding for innovative re-
search and the development of new treatment options and 
diagnostic tools; 
Whereas traditionally, on the first Saturday in May, sur-
vivors, caregivers, and loved ones walk together through-
VerDate Sep 11 2014 
03:31 May 04, 2017
Jkt 069200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR310.IH
HR310
lotter on DSK5VPTVN1PROD with BILLS
•HRES 310 IH 
out the United States to raise awareness of bladder can-
cer; 
Whereas the Bladder Cancer Advocacy Network and its com-
munity of patients, caregivers, and specialists seek to fos-
ter a community of hope and support, fund and conduct 
research for innovative treatments and diagnostic tools, 
and increase public awareness and understanding of blad-
der cancer; and 
Whereas May would be an appropriate month to designate as 
‘‘National Bladder Cancer Awareness Month’’: Now, 
therefore, be it 
Resolved, That the House of Representatives— 
(1) supports the designation of ‘‘National Blad-
der Cancer Awareness Month’’; 
(2) supports the goals and ideals of ‘‘National 
Bladder Cancer Awareness Month’’; and 
(3) calls on the people of the United States, in-
terested groups, and affected persons to— 
(A) promote awareness of bladder cancer 
and to foster understanding of the impact of 
the disease on patients and their families and 
caregivers; 
(B) take an active role in the fight to end 
bladder cancer; and 
VerDate Sep 11 2014 
03:31 May 04, 2017
Jkt 069200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\HR310.IH
HR310
lotter on DSK5VPTVN1PROD with BILLS